References
- Eyre DR. Collagen cross-linking amino acids. Methods Enzymol 1987; 144: 115–39
- Preedy VR, Shenvood RA, Akpoguma CO, Black D. The urinary excretion of the collagen degration markers pyridinoline and deoxypyridino-line in an experimental rat model of alcoholic bone dims. Alc Alcohol 1991; 26: 191–8
- Delmas PD, Gheyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993; 3: 643–8
- Black D, Duncan A, Robins SP. Quantitative analysis of the pyridhium cross-links of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Analyt Biochem 1988; 169: 197–203
- Delmas PD. Clinical sue of biochemical markers of bone remodeling. Bone 1992; 13: 17–21
- Gunja-Smith Z, Boucek RJ. Collagen cross-link components in human urine. Biochem J 1981; 197: 759–62
- Behrens P, Kujiraoka M, Aĉil Y. Pyndinium crosslinks as a resorption marker in the diagnosis for osteopathy. The XXIVth European Symposium on Calcified Tissues, Calcif Tissue Int 1995; 56: 446
- Eyre DR. New biomarkers of bone resorption. J Clin Endocrinol 1992; 74: 470A-C
- Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem 1983; 94: 1133–6
- Açil Y, Müller PK. A rapid method for the isolation of the mature collagen cross-links, hydroxyl-ysylpyridinoline (HP) and lysylpyridinoline (LP), J Chromatogr A. 1994; 664: 183–8
- Beardsworth W, Eyre DR, Dickson IR. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res 1990; 5: 671–6
- Colwell A, Russell RGG, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993; 23: 341–9
- Ohishi T, Takahashi M, Kawana K, Aoshima H, Hoshino H, Horiuchi K, et al. Age-related changes of urinary pyridinohe and deoxypyridinoline in Japanese subje-cts. Clin Invest 1993; 16: 319–25
- Gough AKS, Peel NFA, Eastel R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994; 53: 14–17
- Delmas PD, Schlemmer A, Gheyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991; 6: 639–43
- Açil Y, Vetter U, Brenner R, Müller PK, Brinckmann J. Ehlers-Danlos type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dennatol 1995; 33: 522–4
- Bätge B, Açil Y, Schlatterer A, Seitzer U, Müller PK. Pyridinium-Quervernetzungen im Knochengewebe: Vergleich mit Kollagen-modifikation und Morphometrie. Osteologie 1993; 3(2)119–24
- Body JJ, Delmas PD. Urinary pyridinium crosslinks as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 1992; 74: 471–5
- Fukoka H, Kiriama M, Nishimura Y, Higurashi M, Suzuki Y, Gunji A. Metabolic turnover of bone and peripheral monocytes during short-term bed rest. Acta Physiol Scand 1994; 616: 37–41, Suppl
- Schlemmer A, Hassager C, Jensen SB, Christiansen C. Marked diurnal variations in urinary excretion of pyridinium cross-links in pre-menopausal women. J Clin Endocrinol Metab 1992; 74: 476–80
- Rauch F, Schonau E, Woitge H, Remer T, Seibel M. Urinary excretion of hydroxypyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol 1994; 102: 94–7
- Christiansen C. Skeletal osteoporosis. J Bone Mineral Res 1993; 8: S475–9, Suppl 2
- Teegarden D, Proulx WR, Martin BR, Zhao J, McCabe GP, Lyle RM, et al. Peak bone mass in young women. J Bone Mineral Res 1995; 10: 711–15
- Kirsch E, Krieg T, Remberger K, Fendel H, Müller PK. Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen types I and III. Eur J Clin Invest 1981; 11: 39–47